Cite

HARVARD Citation

    Qin, Y. et al. (2018). Bone‐targeted delivery of TGF‐β type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati–Engelmann disease. Annals of the New York Academy of Sciences. 1433 (1), pp. 29-40. [Online]. 
  
Back to record